These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12415601)

  • 1. Active ingredient consistency of commercially available glucosamine sulfate products.
    Russell AS; Aghazadeh-Habashi A; Jamali F
    J Rheumatol; 2002 Nov; 29(11):2407-9. PubMed ID: 12415601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
    Draves AH; Walker SE
    Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label development and the label comprehension study for over-the-counter drugs.
    Brass EP; Weintraub M
    Clin Pharmacol Ther; 2003 Nov; 74(5):406-12. PubMed ID: 14586381
    [No Abstract]   [Full Text] [Related]  

  • 4. Obstruction of critical information on over-the-counter medication packages by external tags.
    Sansgiry SS; Pawaskar MD
    Ann Pharmacother; 2005 Feb; 39(2):249-54. PubMed ID: 15644473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts in the therapeutic management of osteoarthritis with glucosamine.
    Reginster JY; Bruyere O; Fraikin G; Henrotin Y
    Bull Hosp Jt Dis; 2005; 63(1-2):31-6. PubMed ID: 16536216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of vitamin and mineral tablets and capsules on the Canadian market.
    Löbenberg R; Steinke W
    J Pharm Pharm Sci; 2006; 9(1):40-9. PubMed ID: 16849007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drug label spells it out simply.
    Nordenberg T
    FDA Consum; 1999; 33(4):29-32. PubMed ID: 10443179
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of implementation of the Canadian regulatory requirements on the quality of natural health products: the glucosamine case.
    Aghazadeh-Habashi A; Duke J; Jamali F
    J Pharm Pharm Sci; 2014; 17(1):20-4. PubMed ID: 24735759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of pregnancy warnings on over-the-counter dermatologic products containing potentially harmful hydroquinone.
    Bio LL; Cies JJ
    J Perinatol; 2017 Jul; 37(7):778-781. PubMed ID: 28358386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of single particle aerosol mass spectrometry for the automated nondestructive identification of drugs in multicomponent samples.
    Martin AN; Farquar GR; Steele PT; Jones AD; Frank M
    Anal Chem; 2009 Nov; 81(22):9336-42. PubMed ID: 19842633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of chondroitin sulfate A, chondroitin sulfate C, glucosamine hydrochloride and glucosamine 6 sulfate using chemometric techniques.
    Foot M; Mulholland M
    J Pharm Biomed Anal; 2005 Jul; 38(3):397-407. PubMed ID: 15925239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug packaging.
    Doyle DJ
    CMAJ; 1997 Mar; 156(6):764-5. PubMed ID: 9084377
    [No Abstract]   [Full Text] [Related]  

  • 16. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence study of 500 mg glucosamine sulfate in Thai healthy volunteers.
    Akarasereenont P; Chatsiricharoenkul S; Pongnarin P; Sathirakul K; Kongpatanakul S
    J Med Assoc Thai; 2009 Sep; 92(9):1234-9. PubMed ID: 19772185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia.
    Yang D; Plianbangchang P; Visavarungroj N; Rujivipat S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):741-7. PubMed ID: 15689098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Mar; 74(43):9759-65. PubMed ID: 19418638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.